查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
重組蛋白市場規模、份額、趨勢分析報告，按宿主細胞（昆蟲細胞、哺乳動物）、應用（研究、治療）、產品/服務、最終用戶、地區、細分市場、2022~2030 年預測
市場調查報告書
商品編碼
1122234

重組蛋白市場規模、份額、趨勢分析報告，按宿主細胞（昆蟲細胞、哺乳動物）、應用（研究、治療）、產品/服務、最終用戶、地區、細分市場、2022~2030 年預測

Recombinant Proteins Market Size, Share & Trends Analysis Report By Host Cell (Insect Cells, Mammalian), By Application (Research, Therapeutics), By Product & Services, By End-user, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

重組蛋白市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，預計到 2030 年，重組蛋白的全球市場規模將達到 50.9 億美元，在預測期內的複合年增長率為 12.0%。多發性硬化症、中性粒細胞減少症、中風、貧血和侏儒症等疾病正變得司空見慣，推動了對重組蛋白藥物的需求。此外，由於癌症發病率和患病率的上升以及研發活動的擴大，對生物仿製藥、生物製劑和重組蛋白開發的關注正在增加。

根據美國癌症協會的數據，到 2022 年，將有 190 萬例新癌症病例和 609,360 例癌症相關死亡。此外，重組蛋白在 ELISA、蛋白質印跡和免疫組織化學 (IHC) 等臨床診斷中的應用不斷擴大，預計將推動市場擴張。由於研發成本上升、癌症患者數量增加以及對新穎和個性化治療的需求等因素，預計全球行業將在預測期內顯著擴張。由於努力了解病毒動力學，重組蛋白領域的研究活動隨著 COVID-19 大流行而增加。通過量身定制的治療方法，重組蛋白的產量顯著增加。

此外，隨著研究資金變得更加容易獲得，預計重組蛋白的需求和生產，尤其是與 COVID-19 相關的免疫反應蛋白，將會增加。重組蛋白質被認為是天然蛋白質的改進版本，可以通過多種方式生產以提高蛋白質產量、創造有用的商業產品或改變基因序列。製藥公司不斷增加的研發支出、慢性病的高發病率、不斷增加的監管要求以及減少病毒感染的持續需求是全球行業的主要驅動力。

在預測期內，預計全球行業將受到重組蛋白合成技術進步的推動。例如，2022年6月，根據美國生物技術信息中心提供的數據，CRISPR/Cas9、TALENs、鋅指介導、轉基因或順基因技術等新育種技術無法進行離體基因編輯或基因操作。 . 較新的技術，更容易獲批，有這樣的技術。由於人口老齡化、收入水平上升、醫療保健基礎設施改善、醫療保健成本上升以及新興經濟體低成本製造業的好處，行業參與者也有望在該地區投資，從而推動市場增長。

重組蛋白市場報告亮點

按產品和服務來看，產品類別將在 2021 年佔銷售額的最大份額。生物醫學研究對重組蛋白產品的需求以及抗癌研究和開發的資金不斷增加，在全球範圍內增加了對重組蛋白產品的需求

由於代謝紊亂、癌症、遺傳疾病和免疫紊亂等多種疾病的流行，治療藥物應用板塊在 2021 年的收入份額佔比最大。

製藥和生物技術公司的最終用戶部門看到主要市場參與者增加了對研發的投資，以提高研究生產力並擴大產品供應以創收，從而在 2021 年引領全球行業。

由於哺乳動物系統廣泛用於重組蛋白生產，該部分在 2021 年的收入份額佔最大份額

由於慢性病發病率上升、尖端療法的使用、主要參與者的存在以及醫療保健成本上升，北美將在 2021 年成為主要地區。

由於研發活動增加、可支配收入增加以及患者對蛋白質療法的了解提高，預計亞太地區將在預測期內以最快的速度增長。

此外，印度和中國預計將在亞太地區快速增長

內容

第一章研究方法

  • 市場細分和範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • Gvr 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算國別市場
  • 全球市場：CAGR 計算
  • 調查假設
  • 二級信息列表
  • 主要信息列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 市場概覽

第 3 章市場變量、趨勢和範圍

  • 市場趨勢和前景
  • 市場細分和範圍
  • 市場動態
    • 市場驅動因素分析
      • 增加藥物開發和精準醫學的研究活動
      • 生物製劑和生物仿製藥的採用率增加
      • 增加對研發活動的投資
    • 市場約束分析
      • 蛋白質生產的監管和安全問題
      • 缺乏熟練的人員和專業知識
    • 市場機會分析
      • 治療性重組蛋白的成本降低和生物仿製藥的出現
      • 創新技術可降低重組蛋白生產成本
  • 商業環境分析工具
    • 害蟲的 SWOT 分析
    • 波特五力分析
  • 2021 年產品滲透率和增長前景圖
  • 重組蛋白市場：COVID-19 的影響分析

第四章產品細分分析

  • 重組蛋白市場：產品差異分析
  • 產品
    • 細胞因子和生長因子
      • 干擾素
      • 白細胞介素
      • 其他
    • 抗體
    • 免疫檢查點蛋白
    • 病毒抗原
    • □
      • 激□
      • 代謝□
      • 其他
    • 重組調節蛋白
    • 激素
    • 其他
  • 製作服務

第五章應用細分分析

  • 重組蛋白市場：應用變化分析
  • 藥物發現和開發
  • 治療學
    • 生物製品
    • 疫苗
    • 細胞和基因治療
    • 其他
  • 調查
  • 其他

第 6 章最終用戶細分分析

  • 重組蛋白市場：最終用戶差異分析
  • 製藥和生物技術公司
  • 學術和研究機構
  • 診斷實驗室
  • 其他

第 7 章宿主細胞片段分析

  • 重組蛋白市場：宿主細胞的變異分析
  • 哺乳動物系統
  • 昆蟲細胞
  • 酵母和真菌
  • 細菌細胞
  • 其他

第八章區域展望

  • 重組蛋白市場：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲 (Mea)
    • 南非
    • Ue
    • 沙特阿拉伯

第 9 章競爭格局

  • 戰略框架
  • 市場參與的分類
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Abcam plc
      • 公司概況
      • 財務表現
      • 產品/服務基準
      • 戰略舉措
    • Bio-Rad Laboratories, Inc.
      • 公司概況
      • 財務表現
      • 產品/服務基準
      • 戰略舉措
    • Bio-Techne Corporation
      • 公司概況
      • 研發體系
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Merck KGaA
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • GenScript Biotech Corporation
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • RayBiotech Life, Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Proteintech Group, Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Enzo Life Sciences, Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • STEMCELL Technologies Inc
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Sino Biological, Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Abnova Corporation
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-974-2

Recombinant Proteins Market Growth & Trends:

The global recombinant proteins market size is expected to reach USD 5.09 billion by 2030, registering a CAGR of 12.0% over the forecast period, according to a new report by Grand View Research, Inc. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth.The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

According to the American Cancer Society, in 2022, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period.Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19.Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The rise in pharmaceutical firms' R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections are the main drivers of the global industry.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

Recombinant Proteins Market Report Highlights:

  • By product & services, the product segment accounted for the largest revenue share in 2021. The demand is increasing globally due to the need for recombinant protein products in biomedical research and increased funding for R&D in the fight against cancer
  • The therapeutics application segment held themaximum revenue share in 2021 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases
  • The pharma & biotech companies end-user segment led the global industry in 2021 due to the increasing investments by key market players in their R&D segment to increase research productivity and grow their offerings for revenue generation
  • Mammalian systems are widely used in the production of recombinant proteins, thus, this segment accounted for the largest revenue share in 2021
  • North America was the dominant region in 2021 dueto an increase in the incidence of chronic diseases, use of cutting-edge treatments, presence of key players, and rise in healthcare spending in the region
  • Asia Pacific is expected to grow at the fastestCAGRover the projected period due to an uptick in R&D activity, an increase in disposable incomes, and a better understanding of protein therapies among patients
  • India and China are additionally anticipated to see rapid growth in the AsiaPacific region

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outllook
  • 2.2 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Market Segmentation And Scope
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing Research Activities For Drug Development And Precision Medicine
      • 3.3.1.2 Rising Adoption Of Biologics And Biosimilars
      • 3.3.1.3 Increasing Investments In Research & Development Activities
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Regulatory And Safety Concerns With Protein Production
      • 3.3.2.2 Dearth Of Skilled Personnel And Expertise
    • 3.3.3 Market Opportunity Analysis
      • 3.3.3.1 Declining Cost Of Therapeutics Recombinant Proteins And Advent Of Biosimilars
      • 3.3.3.2 Innovative Techniques Can Decrease The Recombinant Protein Production Cost
  • 3.4 Business Environment Analysis Tools
    • 3.4.1 Swot Analysis, By Pest
    • 3.4.2 Porter's Five Forces Analysis
  • 3.5 Penetration & Growth Prospect Mapping For Product, 2021
  • 3.6 Recombinant Proteins Market: Covid-19 Impact Analysis

Chapter 4 Product Segment Analysis

  • 4.1 Recombinant Proteins Market: Product Movement Analysis
  • 4.2 Product
    • 4.2.1 Global Recombiant Proteins Product Market, 2018 - 2030 (USD Million)
    • 4.2.2 Cytokines &Growth Factors
      • 4.2.2.1 Global Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
      • 4.2.2.1.1 Interferons
      • 4.2.2.1.1.1 Global Interferons Market, 2018 - 2030 (USD Million)
      • 4.2.2.1.2 Interleukins
      • 4.2.2.1.2.1 Global Interleukins Market, 2018 - 2030 (USD Million)
      • 4.2.2.1.3 Others
      • 4.2.2.1.3.1 Others Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.2.3 Antibodies
      • 4.2.3.1 Global Antibodies Market, 2018 - 2030 (USD Million)
    • 4.2.4 Immune Checkpoint Proteins
      • 4.2.4.1 Global Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
    • 4.2.5 Virus Antigens
      • 4.2.5.1 Global Virus Antigens Market, 2018 - 2030 (USD Million)
    • 4.2.6 Enzymes
      • 4.2.6.1 Global Enzymes Market, 2018 - 2030 (USD Million)
      • 4.2.6.1.1 Kinases
      • 4.2.6.1.1.1 Global Kinases Market, 2018 - 2030 (USD Million)
      • 4.2.6.1.2 Metabolic Enzymes
      • 4.2.6.1.2.1 Global Metabolic Enzymes Market, 2018 - 2030 (USD Million)
      • 4.2.6.1.3 Others
      • 4.2.6.1.3.1 Others Enzymes Market, 2018 - 2030 (USD Million)
    • 4.2.7 Recombinant Regulatory Proteins
      • 4.2.7.1 Global Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
    • 4.2.8 Hormones
      • 4.2.8.1 Global Hormones Market, 2018 - 2030 (USD Million)
    • 4.2.9 Others
      • 4.2.9.1 Others Product Market, 2018 - 2030 (USD Million)
  • 4.3 Production Services
    • 4.3.1 Global Recombiant Proteins Production Services Market, 2018 - 2030 (USD Million)

Chapter 5 Application Segment Analysis

  • 5.1 Recombinant Proteins Market: Application Movement Analysis
  • 5.2 Drug Discovery & Development
    • 5.2.1 Global Drug Discovery & Development, 2018 - 2030 (USD Million)
  • 5.3 Therapeutics
    • 5.3.1 Global Therpeutics Market, 2018 - 2030 (USD Million)
    • 5.3.2 Biologics
      • 5.3.2.1 Global Biologics Market, 2018 - 2030 (USD Million)
    • 5.3.3 Vaccines
      • 5.3.3.1 Global Vaccines Market, 2018 - 2030 (USD Million)
    • 5.3.4 Cell & Gene Therapies
      • 5.3.4.1 Global Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
    • 5.3.5 Others
      • 5.3.5.1 Others Therapeutics Market, 2018 - 2030 (USD Million)
  • 5.4 Research
    • 5.4.1 Global Research Market, 2018 - 2030 (USD Million)
  • 5.5 Other
    • 5.5.1 Other Application Market, 2018 - 2030 (USD Million)

Chapter 6 End-User Segment Analysis

  • 6.1 Recombinant Proteins Market: End-User Movement Analysis
  • 6.2 Pharmaceutical & Biotechnology Companies
    • 6.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3 Academic & Research Institutes
    • 6.3.1 Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4 Diagnostic Laboratories
    • 6.4.1 Global Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Other End-Users, 2018 - 2030 (USD Million)

Chapter 7 Host-Cells Segment Analysis

  • 7.1 Recombinant Proteins Market: Host-Cells Movement Analysis
  • 7.2 Mammalian Systems
    • 7.2.1 Global Mammalian Systems Market, 2018 - 2030 (USD Million)
  • 7.3 Insects Cells
    • 7.3.1 Global Insects Cells Market, 2018 - 2030 (USD Million)
  • 7.4 Yeast & Fungi
    • 7.4.1 Global Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 7.5 Bacterial Cells
    • 7.5.1 Global Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 7.6 Others
    • 7.6.1 Other Host-Cells, 2018 - 2030 (USD Million)

Chapter 8 Regional Outlook

  • 8.1 Recombinant Proteins Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Sain Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.2 China
      • 8.4.2.1 China Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.3 India
      • 8.4.3.1 India Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.4 Japan
      • 8.4.4.1 Japan Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Australia Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa (Mea)
    • 8.6.1 Mea Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.3 Uae
      • 8.6.3.1 Uae Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.4 Saudi Arabia
      • 8.6.4.1 Saudi Arabia Recombinant Proteins Market, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Thermo Fisher Scientific, Inc.
      • 9.3.1.1 Company Overview
      • 9.3.1.2 Financial Performance
      • 9.3.1.3 Product Benchmarking
      • 9.3.1.4 Strategic Initiatives
    • 9.3.2 Abcam plc
      • 9.3.2.1 Company Overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product/Service Benchmarking
      • 9.3.2.4 Strategic Initiatives
    • 9.3.3 Bio-Rad Laboratories, Inc.
      • 9.3.3.1 Company Overview
      • 9.3.3.2 Financial Performance
      • 9.3.3.3 Product/Service Benchmarking
      • 9.3.3.4 Strategic Initiatives
    • 9.3.4 Bio-Techne Corporation
      • 9.3.4.1 Company Overview
      • 9.3.4.1.1 R&D Systems
      • 9.3.4.2 Financial Performance
      • 9.3.4.3 Product Benchmarking
      • 9.3.4.4 Strategic Initiatives
    • 9.3.5 Merck KGaA
      • 9.3.5.1 Company Overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product Benchmarking
      • 9.3.5.4 Strategic Initiatives
    • 9.3.6 GenScript Biotech Corporation
      • 9.3.6.1 Company Overview
      • 9.3.6.2 Financial Performance
      • 9.3.6.3 Product Benchmarking
      • 9.3.6.4 Strategic Initiatives
    • 9.3.7 RayBiotech Life, Inc.
      • 9.3.7.1 Company Overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product Benchmarking
      • 9.3.7.4 Strategic Initiatives
    • 9.3.8 Proteintech Group, Inc.
      • 9.3.8.1 Company Overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product Benchmarking
      • 9.3.8.4 Strategic Initiatives
    • 9.3.9 Enzo Life Sciences, Inc.
      • 9.3.9.1 Company Overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product Benchmarking
      • 9.3.9.4 Strategic Initiatives
    • 9.3.10 STEMCELL Technologies Inc
      • 9.3.10.1 Company Overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product Benchmarking
      • 9.3.10.4 Strategic Initiatives
    • 9.3.11 Sino Biological, Inc.
      • 9.3.11.1 Company Overview
      • 9.3.11.2 Financial Performance
      • 9.3.11.3 Product Benchmarking
      • 9.3.11.4 Strategic Initiatives
    • 9.3.12 Abnova Corporation
      • 9.3.12.1 Company Overview
      • 9.3.12.2 Financial Performance
      • 9.3.12.3 Product Benchmarking
      • 9.3.12.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 4 Global Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 5 Global Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 6 Global Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 7 Global Recombinant Protein Market, by Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 10 North America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 12 North America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 13 US Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 14 US Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 15 US Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 16 US Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 18 Canada Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 19 Canada Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 20 Canada Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 22 Europe Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 23 Europe Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 24 Europe Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 28 Germany Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 29 Germany Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 30 UK Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 31 UK Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 32 UK Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 33 UK Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 34 France Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 35 France Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 36 France Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 37 France Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 38 Italy Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 39 Italy Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 40 Italy Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 41 Italy Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 42 Spain Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 43 Spain Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 44 Spain Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 45 Spain Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 50 Asia Pacific Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 51 China Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 52 China Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 China Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 54 China Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 56 Japan Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 57 Japan Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 58 Japan Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 59 India Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 60 India Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 61 India Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 62 India Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 63 South Korea Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 64 South Korea Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 65 South Korea Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 66 South Korea Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 67 Australia Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 68 Australia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 69 Australia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 70 Australia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 72 Latin America Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 73 Latin America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 74 Latin America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 75 Latin America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 76 Brazil Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 77 Brazil Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 78 Brazil Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 79 Brazil Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 80 Mexico Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 81 Mexico Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 82 Mexico Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 83 Mexico Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 84 Argentina Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 85 Argentina Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 86 Argentina Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 87 Argentina Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 88 Middle East & Africa Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 89 Middle East & Africa Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 90 Middle East & Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 91 Middle East & Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 92 Middle East & Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 93 South Africa Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 94 South Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 95 South Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 96 South Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 97 Saudi Arabia Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 98 Saudi Arabia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 99 Saudi Arabia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 100 Saudi Arabia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 101 UAE Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 102 UAE Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 103 UAE Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 104 UAE Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Recombinant Protein, Market Segmentation
  • FIG. 8 Market Snapshot, 2021
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 16 Global Recombinant Protein Market: Product & Services Movement Analysis
  • FIG. 17 Global Recombinant Protein Market, for Product, 2018 - 2030 (USD Million)
  • FIG. 18 Global Recombinant Protein Market, for Production Services, 2018 - 2030 (USD Million)
  • FIG. 19 Global Recombinant Protein Market: Application Movement Analysis
  • FIG. 20 Global Recombinant Protein Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
  • FIG. 21 Global Recombinant Protein Market, for Therapeutics, 2018 - 2030 (USD Million)
  • FIG. 22 Global Recombinant Protein Market, for Research , 2018 - 2030 (USD Million)
  • FIG. 23 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
  • FIG. 24 Global Recombinant Protein Market: End Use Movement Analysis
  • FIG. 25 Global Recombinant Protein Market, for Pharma & Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 26 Global Recombinant Protein Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 27 Global Recombinant Protein Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • FIG. 28 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • FIG. 29 Global Recombinant Protein Market: Host Cell Movement Analysis
  • FIG. 30 Global Recombinant Protein Market, for Mammalian systems, 2018 - 2030 (USD Million)
  • FIG. 31 Global Recombinant Protein Market, for Insect Cells, 2018 - 2030 (USD Million)
  • FIG. 32 Global Recombinant Protein Market, for Yeast & Fungi, 2018 - 2030 (USD Million)
  • FIG. 33 Global Recombinant Protein Market, for Bacterial Cells, 2018 - 2030 (USD Million)
  • FIG. 34 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • FIG. 35 Regional Marketplace: Key Takeaways
  • FIG. 36 Regional Outlook, 2021 & 2030
  • FIG. 37 Global Recombinant Protein Market: Region Movement Analysis
  • FIG. 38 North America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 39 US Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 40 Canada Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 41 Europe Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 42 Germany Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 43 UK Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 44 France Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 45 Italy Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 46 Spain Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 47 Asia Pacific Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 48 Japan Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 49 China Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 50 India Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 51 Australia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 52 South Korea Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 53 Latin America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 54 Brazil Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 55 Mexico Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 56 Argentina Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 57 Middle East and Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 58 South Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 59 Saudi Arabia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 60 UAE Recombinant Protein Market, 2018 - 2030 (USD Million)